Habib Metropolitan Bank’s board has approved a Rs. 700 million capital injection to strengthen its subsidiary companies.
Read More: New PIA Owners Commit to PSX Listing Within One Year
The Allocation
The infusion will be directed toward the bank’s wholly-owned subsidiaries: HMB Leasing Modaraba and HMB Securities (Private) Limited. The funds are intended to bolster their equity base and support business expansion.
The Rationale
The move aligns with regulatory requirements and the bank’s internal growth strategy. Industry sources indicate the injection will enable the subsidiaries to underwrite larger transactions, enhance lending capacity, and meet minimum capital thresholds set by the Securities and Exchange Commission of Pakistan (SECP).
The Context
HMB Leasing Modaraba operates in the diminishing musharakah and Ijarah space, while HMB Securities is the bank’s investment advisory and brokerage arm. Both entities require adequate capitalization to remain competitive amid rising compliance costs and market volatility.
The Numbers
The Rs. 700 million injection represents a material commitment relative to the subsidiaries’ existing equity bases. Exact pre-injection capital positions were not disclosed in the filing.
The Timing
The infusion is expected to be completed during the current fiscal year, subject to regulatory approvals. The bank has not indicated whether this will be a single tranche or staggered deployment.
The Quote
No official statement from Habib Metro management was included in the exchange filing.
The Bottom Line
Habib Metro is fortifying its non-banking arms—a defensive move to meet regulatory floors and an offensive one to capture modest growth in leasing and securities.
